Evotec shares shot up by over 10% on Friday. Is it due to the payment from the Gates Foundation? Or is there a new attempt to ...

Q1 2025 Earnings Call Transcript May 6, 2025 Evotec SE beats earnings expectations. Reported EPS is $-0.05152, expectations ...

Evotec is a drug discovery partnership firm that has a contract development and manufacturing organization, or CDMO, business, in addition to an innovative drug development program focused on ...

Evotec SE has been awarded a $2.5M grant from The Gates Foundation to support the development of next-gen treatment regimens ...

Despite a dip in group revenues, Evotec SE (EVO) showcases resilience with strong growth in biologics and strategic ...

Analysts expect Evotec to report an earnings per share (EPS) of $-0.24. Evotec bulls will hope to hear the company announce ...

Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations. The collaboration continues a successful ...

Ladies and gentlemen, welcome to the Evotec SE Full-Year Result 2024 Analyst Call. I am Yusuf, the Chorus Call operator. I would like to remind you that all participants will be in a listen-only ...

The company’s net loss before taxes increased to 29.85 million euros, compared to 26.78 million euros a year earlier.

Group revenues of € 200 m, on track towards guidance; Shared R&D with similar trend as 2024; Just - Evotec Biologics with ...

Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations. The collaboration continues a successful ...

Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2025 Conference Call. I am George, the Chorus Call operator. I would like to remind you that all participants will be in ...